[1]
Svetlana, D.; Vinokurova, O.; Zimina, V. Tuberculosis and Diabetes Mellitus Co-morbidity. Curr. Respir. Med. Rev., 2022, 18(4), 231-238. [Typeset editor, please make sure the pagination of this paper is correct.].
[2]
World Health Organization (WHO). Diabetes [Accessed October 20, 2022]. Available from: https: //www.who.int/news-room/fact-sheets/detail/diabetes
[3]
Ronacher, K.; Joosten, S.A.; van Crevel, R.; Dockrell, H.M.; Walzl, G.; Ottenhoff, T.H.M. Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol. Rev., 2015, 264(1), 121-137.
[4]
Giacomini, E.; Iona, E.; Ferroni, L. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol., 2001, 166(12), 7033-7041.
[5]
Hodgson, K.; Morris, J.; Bridson, T.; Govan, B.; Rush, C.; Ketheesan, N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology, 2015, 144(2), 171-185.
[6]
Wang, L.; Shang, X.; Qi, X.; Ba, D.; Lv, J.; Zhou, X.; Wang, H.; Shaxika, N.; Wang, J.; Ma, X. Clinical significance of M1/M2 macrophages and related cytokines in patients with spinal tuberculosis. Dis. Markers, 2020, 2020, 2509454.
[7]
Bensellam, M.; Duvillié, B.; Rybachuk, G. Glucose-induced O2 consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One, 2012, 7(1), e29807.
[8]
Vallerskog, T.; Martens, G.W.; Kornfeld, H. Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J. Immunol., 2010, 184(11), 6275-6282.
[9]
Lachmandas, E.; Thiem, K.; van den Heuvel, C. Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis., 2018, 37(2), 371-380.